Criminalization of scientific misconduct.


Journal

Medicine, health care, and philosophy
ISSN: 1572-8633
Titre abrégé: Med Health Care Philos
Pays: Netherlands
ID NLM: 9815900

Informations de publication

Date de publication:
Jun 2019
Historique:
pubmed: 30 8 2018
medline: 18 12 2019
entrez: 30 8 2018
Statut: ppublish

Résumé

This paper discusses the criminalization of scientific misconduct, as discussed and defended in the bioethics literature. In doing so it argues against the claim that fabrication, falsification and plagiarism (FFP) together identify the most serious forms of misconduct, which hence ought to be criminalized, whereas other forms of misconduct should not. Drawing the line strictly at FFP is problematic both in terms of what is included and what is excluded. It is also argued that the criminalization of scientific misconduct, despite its anticipated benefits, is at risk of giving the false impression that dubious practices falling outside the legal regulation "do not count". Some doubts are also raised concerning whether criminalization of the most serious forms of misconduct will lower the burdens for universities or successfully increase research integrity. Rather, with or without criminalization, other measures must be taken and are probably more important in order to foster a more healthy research environment.

Identifiants

pubmed: 30155851
doi: 10.1007/s11019-018-9865-7
pii: 10.1007/s11019-018-9865-7
pmc: PMC6499870
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

245-252

Références

Sci Eng Ethics. 2002 Apr;8(2):229-34
pubmed: 12092495
J Law Med Ethics. 2005 Summer;33(2):345-8
pubmed: 16083091
Am J Bioeth. 2005 Sep-Oct;5(5):W1-7
pubmed: 16179287
Sci Eng Ethics. 2006 Jan;12(1):53-74
pubmed: 16501647
PLoS One. 2009 May 29;4(5):e5738
pubmed: 19478950
Sci Eng Ethics. 2011 Mar;17(1):21-9
pubmed: 19941087
Sci Am. 2012 Aug;307(2):13
pubmed: 22844847
Psychon Bull Rev. 2012 Dec;19(6):975-91
pubmed: 23055145
Sci Eng Ethics. 2014 Jun;20(2):423-31
pubmed: 23982326
Sci Eng Ethics. 2015 Aug;21(4):813-9
pubmed: 24935246
Med Health Care Philos. 2015 Feb;18(1):91-101
pubmed: 24993050
BMJ. 2014 Jul 15;349:g4532
pubmed: 25027665
Account Res. 2015;22(1):14-21
pubmed: 25275621
Account Res. 2015;22(5):249-66
pubmed: 25928177
Int J Clin Oncol. 2016 Feb;21(1):15-21
pubmed: 26289019
Science. 2015 Aug 28;349(6251):aac4716
pubmed: 26315443
Science. 2016 Mar 4;351(6277):1037
pubmed: 26941312
Sci Eng Ethics. 2018 Feb;24(1):151-171
pubmed: 28281156

Auteurs

William Bülow (W)

Department of Philosophy, Stockholm University, Stockholm, Sweden.

Gert Helgesson (G)

Stockholm Centre for Healthcare Ethics (CHE), Department of Learning, Informatics, Management and Ethics, Karolinska Institutet, Stockholm, Sweden. gert.helgesson@ki.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH